Fig. 5
From: Geijigajakyak decoction inhibits the motility and tumorigenesis of colorectal cancer cells
GJD inhibits tumor growth in a syngeneic mouse tumor model. a Time line for the generation of a mouse tumor xenograft model and the schedule for GJD treatment. Vehicle (PBS) was orally administered to control mice twice a day. Test mice received 333 mg/kg GJD twice a day. b Effect of GJD on tumor formation by CT-26 cells. Tumor volumes, measured daily and calculated using the formula width2 × length × 0.5 (length > width), are expressed as the mean ± SEM. Tumors in the GJD group (n = 7) grew more slowly than those in the control group (n = 7). c Photographs of tumor tissues isolated from each group. d Tumor weights were measured in each group at Day 21. Data are expressed as the mean ± SEM. GJD inhibited tumor formation by CT-26 cells